Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Barkin

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|November 4, 2009
Androgens and sexual function: a placebo-controlled, randomized, double-blind study of testosterone vs. dehydroepiandrosterone in men with sexual dysfunction and androgen deficiencyAlvaro Morales, Angela Black, Laurel Emerson, et al.
The Journal of Urology|July 24, 2018
Oncologic and Functional Outcomes of Partial Gland Ablation with High Intensity Focused Ultrasound for Localized Prostate CancerRoman Bass, Neil Fleshner, Antonio Finelli, et al.
The Journal of Urology|December 23, 2018
Oncologic and Functional Outcomes of Partial Gland Ablation with High Intensity Focused Ultrasound for Localized Prostate CancerRoman Bass, Neil Fleshner, Antonio Finelli, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 1, 2019
The My-T study: Patient satisfaction and preference comparing topical and nasal testosterone therapiesJay Lee, Gerald Brock, Jack Barkin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 1, 2019
MY-T study: Symptom-based titration decisions when using testosterone nasal gel, Natesto<sup>®</sup>Jay Lee, Gerald Brock, Jack Barkin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 18, 2018
Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH): 2018 updateJ Curtis Nickel, Lorne Aaron, Jack Barkin, et al.
The Journal of Urology|June 28, 2017
High Intensity Focused Ultrasound for Radiorecurrent Prostate Cancer: A North American Clinical TrialTonye A Jones, Joseph Chin, David Mcleod, et al.
European Urology|September 15, 2004
Efficacy and safety of long-term treatment with the dual 5 alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasiaFrans Debruyne, Jack Barkin, Peter van Erps, et al.
BJU International|February 26, 2009
Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 2-year data from the CombAT trialJack Barkin, Claus G Roehrborn, Paul Siami, et al.
The Canadian Journal of Urology|February 18, 2014
Prospective multi-center study elucidating patient experience after prostatic urethral liftNeal Shore, Sheldon Freedman, Steven Gange, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|November 4, 2009
Androgens and sexual function: a placebo-controlled, randomized, double-blind study of testosterone vs. dehydroepiandrosterone in men with sexual dysfunction and androgen deficiencyAlvaro Morales, Angela Black, Laurel Emerson, et al.
The Journal of Urology|July 24, 2018
Oncologic and Functional Outcomes of Partial Gland Ablation with High Intensity Focused Ultrasound for Localized Prostate CancerRoman Bass, Neil Fleshner, Antonio Finelli, et al.
The Journal of Urology|December 23, 2018
Oncologic and Functional Outcomes of Partial Gland Ablation with High Intensity Focused Ultrasound for Localized Prostate CancerRoman Bass, Neil Fleshner, Antonio Finelli, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 1, 2019
The My-T study: Patient satisfaction and preference comparing topical and nasal testosterone therapiesJay Lee, Gerald Brock, Jack Barkin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 1, 2019
MY-T study: Symptom-based titration decisions when using testosterone nasal gel, Natesto<sup>®</sup>Jay Lee, Gerald Brock, Jack Barkin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 18, 2018
Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH): 2018 updateJ Curtis Nickel, Lorne Aaron, Jack Barkin, et al.
The Journal of Urology|June 28, 2017
High Intensity Focused Ultrasound for Radiorecurrent Prostate Cancer: A North American Clinical TrialTonye A Jones, Joseph Chin, David Mcleod, et al.
European Urology|September 15, 2004
Efficacy and safety of long-term treatment with the dual 5 alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasiaFrans Debruyne, Jack Barkin, Peter van Erps, et al.
BJU International|February 26, 2009
Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 2-year data from the CombAT trialJack Barkin, Claus G Roehrborn, Paul Siami, et al.
The Canadian Journal of Urology|February 18, 2014
Prospective multi-center study elucidating patient experience after prostatic urethral liftNeal Shore, Sheldon Freedman, Steven Gange, et al.
Pageof 11